EUCTR2009-010260-41-IT进行中（未招募）不适用
Breast cancer prevention with fenretinide in young women at genetic and familial risk. A phase III randomized clinical trial - ND
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •women 25-44 years old with a known BRCA1/2 mutation or with a risk of being a mutation carrier ≥ 20% (BRCAPRO program), performance status=0, avoid pregnancy during treatment and for 12 months after drug cessation, no clinical and radiological evidence of breast and ovarian cancer, signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •History of breast cancer or any other malignancy with the exclusion of CIN and non- melanoma skin cancer, child bearing or breast feeding, previous or current use of SERMs for more than 12 months; if less a two-months wash-out is requested before entering the study
研究者
相似试验
终止
3 期
Fenretinide in Healthy Young Women at Genetic and Familial RiskHigh-Risk CancerNCT01479192European Institute of Oncology20
终止
不适用
Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased RiskOvarian CancerNCT00017134Gynecologic Oncology Group71
进行中（未招募）
不适用
Preventing Breast cancer through Assumption of Metformin, Diet and Physical Activity - Bremet Dietwomen affected by metabolic syndrome defined by at least three out of five metabolic factors: 1-glucose >110 mg/100 mL 2-triglycerides >150mg/100mL 3-HDL cholesterol <50 mg/100mL 4-waist circumference >88 cm) 5-hypertension SBP>130 mm Hg or DBP >85 mm HMedDRA version: 9.1Level: SOCClassification code 10038604MedDRA version: 9.1Level: SOCClassification code 10029104MedDRA version: 9.1Level: PTClassification code 10007649MedDRA version: 9.1Level: SOCClassification code 10022891EUCTR2008-006527-30-ITISTITUTO NAZIONALE PER LA CURA TUMORI
已完成
3 期
Fenretinide in Treating Patients With Cervical NeoplasiaPrecancerous ConditionCervical CancerNCT00003075M.D. Anderson Cancer Center39
已完成
1 期
Fenretinide in Treating Children With Solid TumorsUnspecified Childhood Solid Tumor, Protocol SpecificNeuroblastomaNCT00003191National Cancer Institute (NCI)18